Tesnime Jebara

Tesnime Jebara

Auto-generated profile, based on publicly available information

Tesnime Jebara

School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2018 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
TJTesnime Jebara
Tesnime Jebara
SCScott Cunningham
Scott Cunningham
Katie MacLureKatie MacLure
Katie MacLure
AAAhmed Awaisu
Ahmed Awaisu
APAbdulrouf Pallivalapila
Abdulrouf Pallivalapila
DSDerek Stewart
Derek Stewart
Aims: The aims of this systematic review were to: (1) critically appraise, synthesize and present the available evidence on the views and experiences of stakeholders on pharmacist prescribing and; (2) present the perceived facilitators and barriers for its global implementation.Methods: Medline, CINAHL, International Pharmaceutical Abstracts, PsychArticles and Google Scholar databases were searched. Study selection, quality assessment and data extraction were conducted independently by two reviewers. A narrative approach to data synthesis was undertaken due to heterogeneity, the nature of study types and outcome measures.Results: Sixty‐five studies were identified, mostly from the UK (n = 34), followed by Australia (n = 13), Canada (n = 6) and USA (n = 5). Twenty‐seven studies reported pharmacists' perspectives, with fewer studies focusing on patients' (n = 12), doctors' (n = 6), the general public's (n = 4), nurses' (n = 1), policymakers' (n = 1) and multiple stakeholders' (n = 14) perspectives. Most reported positive experiences and views, regardless of stage of implementation. The main benefits described were: ease of patient access to healthcare services, improved patient outcomes, better use of pharmacists' skills and knowledge, improved pharmacist job satisfaction, and reduced physician workload. Any lack of support for pharmacist prescribing was largely in relation to: accountability for prescribing, limited pharmacist diagnosis skills, lack of access to patient clinical records, and issues concerning organizational and financial support.Conclusion: There is an accumulation of global evidence of the positive views and experiences of diverse stakeholder groups and their perceptions of facilitators and barriers to pharmacist prescribing. There are, however, organizational issues to be tackled which may otherwise impede the implementation and sustainability of pharmacist prescribing.

1 February 2017 in Therapeutic Advances in Drug Safety
Verified
Journal Article
Open access
DSDerek Stewart
Derek Stewart
TJTesnime Jebara
Tesnime Jebara
SCScott Cunningham
Scott Cunningham
AAAhmed Awaisu
Ahmed Awaisu
APAbdulrouf Pallivalapila
Abdulrouf Pallivalapila
Katie MacLureKatie MacLure
Katie MacLure
Many countries have implemented nonmedical prescribing (NMP) and many others are scoping prescribing practices with a view to developing NMP. This paper provides a future perspective on NMP in light of findings of an umbrella review of aspects of NMP. This is followed by coverage of the Scottish Government strategy of pharmacist prescribing and finally, consideration of two key challenges. The review identified seven systematic reviews of influences on prescribing decision-making, processes of prescribing, and barriers and facilitators to implementation. Decision making was reported as complex with many, and often conflicting, influences. Facilitators of NMP included perceived improved patient care and professional autonomy, while barriers included lack of defined roles and resource pressures. Three systematic reviews explored patient outcomes that were noted to be equivalent or better to physician prescribing. In particular, a Cochrane review of 46 studies of clinical, patient-reported, and resource-use outcomes of NMP compared with medical prescribing showed positive intervention-group effects. Despite positive findings, authors highlighted high bias, poor definition and description of ‘prescribing’ and the ‘prescribing process’ and difficulty in separating NMP effects from the contributions of other healthcare team members. While evidence of benefit and safety is essential to inform practice, for NMP to be implemented and sustained on a large scale, there needs to be clear commitment at the highest level. The approach being taken by the Scottish Government to pharmacist prescribing implementation may inform developments in other professions and countries. The vision is that by 2023, all pharmacists providing pharmaceutical care will be pharmacist-independent prescribers. There are, however, challenges to implementing NMP into working practice; two key challenges are the need for sustainable models of care and evaluation research. These challenges could be met by considering the theoretical basis for implementation, and robust and rigorous evaluation.

1 June 2020 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
TJTesnime Jebara
Tesnime Jebara
SCScott Cunningham
Scott Cunningham
Katie MacLureKatie MacLure
Katie MacLure
APAbdulrouf Pallivalapila
Abdulrouf Pallivalapila
AAAhmed Awaisu
Ahmed Awaisu
DSDerek Stewart
Derek Stewart

17 June 2015 in Journal of Pharmaceutical Health Services Research
Verified
Journal Article
Closed access
PDF file
AAAhmed Awaisu
Ahmed Awaisu
Nadir  KheirNadir Kheir
Nadir Kheir
HAHanen Ali Alrowashdeh
Hanen Ali Alrowashdeh
SASoumaya Najib Allouch
Soumaya Najib Allouch
TJTesnime Jebara
Tesnime Jebara
MIMohamed Izham Ibrahim
Mohamed Izham Ibrahim

22 September 2020 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
TJTesnime Jebara
Tesnime Jebara
SCScott Cunningham
Scott Cunningham
Katie MacLureKatie MacLure
Katie MacLure
AAAhmed Awaisu
Ahmed Awaisu
APAbdulrouf Pallivalapila
Abdulrouf Pallivalapila
DSDerek Stewart
Derek Stewart
Background In Qatar, the National Vision 2030 and the National Health Strategy 2018–2022 articulate the need to improve healthcare delivery by better utilisation of the skilled workforce. In this regard, pharmacy practice is rapidly advancing and several extended pharmacy services are now available in institutionalised settings. Objective This study aimed to determine health-related stakeholders’ perceptions of current clinical pharmacy services in Qatar, and the potential development and implementation of further patient-centred roles. Setting All major organisations and institutions relating to the practice, education, regulation, and governance of pharmacy in Qatar. Method Qualitative, face-to-face semi-structured interviews were conducted with individuals in key strategic positions of policy development and influence (i.e. health-related academic leaders, healthcare policy developers, directors of medicine/pharmacy/nursing, and patient safety leaders). Participants were recruited via a combination of purposeful and snowball sampling, until the point of data saturation was reached. The interview guide was grounded in the Consolidated Framework for Implementation Research domains of innovation characteristics, outer and inner setting, characteristics of individuals, and implementation process. The interviews were digitally recorded, transcribed and independently analysed by two researchers using the Framework approach. Main outcome measure Perceptions of stakeholders regarding current and potential for future clinical pharmacy services in Qatar. Results Thirty-seven interviews were conducted with stakeholders of policy influence in healthcare. The interviewees reported a variety of clinical pharmacy services available in Qatar, which they perceived as positively impacting patient care outcomes, pharmacists’ professional autonomy, and the healthcare system in general (innovation characteristics). However, they perceived that these services were mainly performed in hospitals and less in community pharmacy setting (inner setting) and were undervalued by patients and the public (outer setting). Expansion of pharmacists’ clinical activities was supported, with recognition of facilitators such as the skillset and training of pharmacists, potential time release due to automation and well-considered implementation processes (characteristics of individuals, inner setting, process). Conclusion Health-related stakeholders in Qatar have positive perceptions of current clinical pharmacy services and support the expansion of pharmacist’s roles. However, service development needs to consider the issues of patient and public awareness and initially target institutionalised healthcare settings.

1 July 2023 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
TJTesnime Jebara
Tesnime Jebara
EYElaine Youngson
Elaine Youngson
NDNatalie Drummond
Natalie Drummond
GRGordon Rushworth
Gordon Rushworth
SPSharon Pfleger
Sharon Pfleger
SCScott Cunningham
Scott Cunningham
Background: The World Health Organization predicts that the number of older adults will nearly double between 2015 and 2050. Older adults are at a higher risk of developing medical conditions such as chronic pain. However, there is little information about chronic pain and its management in older adults especially those residing in remote and rural areas. Aim: To explore views, experiences, and behavioural determinants of older adults regarding chronic pain management in remote and rural settings in Scottish Highlands. Method: Qualitative one-to-one telephone interviews were conducted with older adults with chronic pain residing in remote and rural areas in the Scottish Highlands. The interview schedule was developed by the researchers, validated, and piloted prior to use. All interviews were audio-recorded, transcribed, and independently thematically-analysed by two researchers. Interviews continued until data saturation. Results: Fourteen interviews were conducted with three key themes emerging: views and experiences with chronic pain, need to enhance pain management, and perceived barriers to pain management. Overall, pain was reported as severe and negatively impacted lives. Majority of interviewees used medicines for pain relief but noted that their pain was still poorly controlled. Interviewees had limited expectation for improvement since they considered their condition a normal consequence of ageing. Residing in remote and rural areas was perceived to complicate access to services with many having to travel long distances to see a health professional. Conclusion: Chronic pain management in remote and rural areas remains a significant issue among older adults interviewed. Thus, there is a need to develop approaches to improve access to related information and services.